Novavax Aktie
7,82
EUR
-0,09
EUR
-1,09
%
9,19
USD
+0,12
USD
+1,27
%
Novavax jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 5 | 3 | 0 | 137,30 GBP | - |
| Bayer | 2 | 7 | 0 | 26,88 EUR | -2,71% |
| BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +28,69% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 3 | 4 | 3 | 47,89 EUR | +4,77% |
| Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 50,81 EUR | +8,96% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 1 | 0 | 42,00 USD | +52,51% |
| Novartis AG | 3 | 4 | 2 | 98,25 CHF | -6,80% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 4 | 0 | 29,33 USD | +10,97% |
| Roche AG (Genussschein) | 3 | 2 | 3 | 278,50 CHF | -3,67% |
| Sanofi S.A. | 8 | 1 | 0 | 109,50 EUR | +27,22% |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |